-
1
-
-
69449090120
-
Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009
-
Goldhirsch A., Ingle J.N., Gelber R.D., et al. Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009, 20:1319-1329.
-
(2009)
Ann Oncol
, vol.20
, pp. 1319-1329
-
-
Goldhirsch, A.1
Ingle, J.N.2
Gelber, R.D.3
-
2
-
-
34247569300
-
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype
-
Bauer K.R., Brown M., Cress R.D., et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer 2007, 109:1721-1728.
-
(2007)
Cancer
, vol.109
, pp. 1721-1728
-
-
Bauer, K.R.1
Brown, M.2
Cress, R.D.3
-
4
-
-
40949121882
-
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype
-
Cheang M.G., Voduc D., Bajdik C., et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008, 14:1368-1376.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1368-1376
-
-
Cheang, M.G.1
Voduc, D.2
Bajdik, C.3
-
5
-
-
34247381115
-
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
-
Haffty B.G., Yang Q., Reiss M., et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 2006, 24:5652-5657.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5652-5657
-
-
Haffty, B.G.1
Yang, Q.2
Reiss, M.3
-
6
-
-
48649108724
-
The prognostic importance of triple negative breast carcinoma
-
Mersin H., Yildirim E., Berberoglu U., et al. The prognostic importance of triple negative breast carcinoma. Breast 2008, 17:341-346.
-
(2008)
Breast
, vol.17
, pp. 341-346
-
-
Mersin, H.1
Yildirim, E.2
Berberoglu, U.3
-
7
-
-
0035751675
-
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
-
Wolmark N., Wang J., Mamounas E., et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001, 30:96-102.
-
(2001)
J Natl Cancer Inst Monogr
, vol.30
, pp. 96-102
-
-
Wolmark, N.1
Wang, J.2
Mamounas, E.3
-
8
-
-
0037087562
-
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel
-
Smith I.C., Heys S.D., Hutcheon A.W., et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 2002, 20:1456-1466.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1456-1466
-
-
Smith, I.C.1
Heys, S.D.2
Hutcheon, A.W.3
-
9
-
-
33646375742
-
Recommendations from an international expert panel on the use of neoadjuvant primary systemic treatment of operable breast cancer: an update
-
Kaufmann M., Hortobagyi G.N., Goldhirsch A., et al. Recommendations from an international expert panel on the use of neoadjuvant primary systemic treatment of operable breast cancer: an update. J Clin Oncol 2006, 24:1940-1949.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1940-1949
-
-
Kaufmann, M.1
Hortobagyi, G.N.2
Goldhirsch, A.3
-
10
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. JNCI 2000, 92:205-216.
-
(2000)
JNCI
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
11
-
-
8944233855
-
Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging
-
Abraham D.C., Jones R.C., Jones S.E., et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996, 78:91-100.
-
(1996)
Cancer
, vol.78
, pp. 91-100
-
-
Abraham, D.C.1
Jones, R.C.2
Jones, S.E.3
-
12
-
-
0036111233
-
Imaging in evaluation of response to neoadjuvant breast cancer treatment: benefits of MRI
-
Balu-Maestro C., Chapellier C., Bleuse A., et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment: benefits of MRI. Breast Cancer Res Treat 2002, 72:145-152.
-
(2002)
Breast Cancer Res Treat
, vol.72
, pp. 145-152
-
-
Balu-Maestro, C.1
Chapellier, C.2
Bleuse, A.3
-
13
-
-
0034999791
-
MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation
-
Weatherall P.T., Evans G.F., Metzger G.J., et al. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 2001, 13:868-875.
-
(2001)
J Magn Reson Imaging
, vol.13
, pp. 868-875
-
-
Weatherall, P.T.1
Evans, G.F.2
Metzger, G.J.3
-
14
-
-
3042514833
-
Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy
-
Londero V., Bazzocchi M., Frate C.D., et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004, 14:1371-1379.
-
(2004)
Eur Radiol
, vol.14
, pp. 1371-1379
-
-
Londero, V.1
Bazzocchi, M.2
Frate, C.D.3
-
15
-
-
37449021466
-
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
-
Chen J.H., Feig B., Agrawal G., et al. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 2008, 112:17-26.
-
(2008)
Cancer
, vol.112
, pp. 17-26
-
-
Chen, J.H.1
Feig, B.2
Agrawal, G.3
-
16
-
-
0037368147
-
Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI
-
Cheung Y.C., Chen S.C., Su M.Y., et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 2003, 78:51-58.
-
(2003)
Breast Cancer Res Treat
, vol.78
, pp. 51-58
-
-
Cheung, Y.C.1
Chen, S.C.2
Su, M.Y.3
-
17
-
-
0030917656
-
MRI of breast cancer: influence of chemotherapy on sensitivity
-
Rieber A., Zeitler H., Rosenthal H., et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997, 70:452-458.
-
(1997)
Br J Radiol
, vol.70
, pp. 452-458
-
-
Rieber, A.1
Zeitler, H.2
Rosenthal, H.3
-
18
-
-
0036634844
-
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy
-
Rieber A., Brambs H.J., Gabelmann A., et al. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002, 12:1711-1719.
-
(2002)
Eur Radiol
, vol.12
, pp. 1711-1719
-
-
Rieber, A.1
Brambs, H.J.2
Gabelmann, A.3
-
19
-
-
58149198586
-
Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer
-
Ah-See M.L., Makris A., Taylor N.J., et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 2008, 14:6580-6589.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6580-6589
-
-
Ah-See, M.L.1
Makris, A.2
Taylor, N.J.3
-
20
-
-
19844379970
-
MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results
-
Khoury C.E., Servois V., Thibault F., et al. MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results. Am J Roentgenol 2005, 184:1499-1504.
-
(2005)
Am J Roentgenol
, vol.184
, pp. 1499-1504
-
-
Khoury, C.E.1
Servois, V.2
Thibault, F.3
-
21
-
-
34047271610
-
Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study
-
Chou C.P., Wu M.T., Chang H.T., et al. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Acad Radiol 2007, 14:561-573.
-
(2007)
Acad Radiol
, vol.14
, pp. 561-573
-
-
Chou, C.P.1
Wu, M.T.2
Chang, H.T.3
-
22
-
-
62649148448
-
Triple-negative breast cancer: correlation between MR imaging and pathologic findings
-
Uematsu T., Kasami M., Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 2009, 250:638-647.
-
(2009)
Radiology
, vol.250
, pp. 638-647
-
-
Uematsu, T.1
Kasami, M.2
Yuen, S.3
-
23
-
-
0027529425
-
Pathologic findings from the National Surgical Adjuvant Breast Project B-06: 10-year pathologic and clinical prognostic discriminants
-
Fisher E.R., Anderson S., Redmond C., et al. Pathologic findings from the National Surgical Adjuvant Breast Project B-06: 10-year pathologic and clinical prognostic discriminants. Cancer 1993, 71:2507-2514.
-
(1993)
Cancer
, vol.71
, pp. 2507-2514
-
-
Fisher, E.R.1
Anderson, S.2
Redmond, C.3
-
24
-
-
0035110549
-
Centrally necrotizing carcinoma of the breast: a distinct histologic subtype with aggressive clinical behavior
-
Jimenez R.E., Wallis T., Visscher D.W. Centrally necrotizing carcinoma of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol 2001, 25:331-337.
-
(2001)
Am J Surg Pathol
, vol.25
, pp. 331-337
-
-
Jimenez, R.E.1
Wallis, T.2
Visscher, D.W.3
-
25
-
-
0033067163
-
Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
-
Leek R.D., Landers R.J., Harris A.L., et al. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999, 79:991-995.
-
(1999)
Br J Cancer
, vol.79
, pp. 991-995
-
-
Leek, R.D.1
Landers, R.J.2
Harris, A.L.3
-
26
-
-
0038417029
-
Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3
-
Metz S., Daldrup-Link H.E., Richter T., et al. Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3. Acad Radiol 2003, 10:484-490.
-
(2003)
Acad Radiol
, vol.10
, pp. 484-490
-
-
Metz, S.1
Daldrup-Link, H.E.2
Richter, T.3
|